C07C 39/26
Monocyclic monohydroxylic containing halogen bound to ring carbon atoms
Official title: monocyclic monohydroxylic containing halogen bound to ring carbon atoms
C07C39/26 (Monocyclic monohydroxylic containing halogen bound to ring carbon atoms) appears on 67 US grants and 51 published applications in this corpus.
Search patents in C07C- Granted patents
- 67
- Published applications
- 51
- Assignees
- 54
- Inventors
- 192
- Latest grant
- 2 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 2 |
| 2009 | 1 | 3 |
| 2010 | 1 | 4 |
| 2011 | 2 | 1 |
| 2012 | 4 | 5 |
| 2013 | 4 | 4 |
| 2014 | 3 | 1 |
| 2015 | 0 | 4 |
| 2016 | 1 | 1 |
| 2017 | 1 | 4 |
| 2018 | 0 | 2 |
| 2019 | 3 | 3 |
| 2020 | 2 | 4 |
| 2021 | 4 | 2 |
| 2022 | 1 | 4 |
| 2023 | 3 | 1 |
| 2024 | 2 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Processes for making modulators of cystic fibrosis transmembrane conductance regulator2 Jul 2024US 12,024,491 B2Vertex Pharmaceuticals Incorporated
- Arylamide derivative having antitumor activity23 Apr 2024US 11,964,950 B2Chugai Seiyaku Kabushiki Kaisha
- FXR (NR1H4) modulating compounds29 Aug 2023US 11,739,065 B2Gilead Sciences, Inc.
- Processes for making modulators of cystic fibrosis transmembrane conductance regulator25 Jul 2023US 11,708,331 B2Vertex Pharmaceuticals Incorporated
- Compounds for the treatment of neuromuscular disorders28 Feb 2023US 11,591,284 B2Nmd Pharma A/S
- Synthetic Cannabinoid Compounds, Pharmaceutical Compositions, and Treatment Methods31 Oct 2024US 2024/0360061 A1Miralogx LLC
- Arylamide derivative having antitumor activity25 Jul 2024US 2024/0246922 A1Chugai Seiyaku Kabushiki Kaisha
- Processes for making modulators of cystic fibrosis transmembrane conductance regulator23 May 2024US 2024/0166607 A1Vertex Pharmaceuticals Incorporated
- Arylamide derivative having antitumor activity5 Jan 2023US 2023/0002333 A1Chugai Seiyaku Kabushiki Kaisha
- Compound, polymer, composition, composition for film formation, pattern formation method, insulating film formation method, and method for producing compound, as well as method for producing iodine-containing vinyl polymer and acetylated derivative thereof3 Nov 2022US 2022/0348698 A1Mitsubishi Gas Chemical Company, Inc.
Most cited
By later US patents
- Compounds and methods for kinase modulation, and indications therefor151US 7,863,288 B2Plexxikon Inc. · 2011
- 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides122US 7,314,849 B2Dow AgroSciences LLC · 2008
- Compounds and methods for kinase modulation, and indications therefor118US 8,143,271 B2Plexxikon Inc. · 2012
- Compounds and methods for kinase modulation, and indications therefor90US 8,470,818 B2Plexxikon Inc. · 2013
- Compounds and methods for kinase modulation, and indications therefor84US 8,415,469 B2Plexxikon Inc. · 2013